Robert Bell

Dr. Robert Bell is the Chief Scientific Officer of ARS Pharmaceuticals, Inc. He brings more than 30 years of multidisciplinary experience in strategic global business development, product registration and commercialization of new drugs, biologics, devices and generic drug products. Dr. Bell also has extensive expertise with global business collaborations and product development efforts that have resulted in product approvals and new market opportunities.

Prior to joining ARS Pharmaceuticals, Inc., Dr. Bell held various leadership positions in the pharmaceutical industry, serving as Vice President, New / Strategic Drug Development at Barr Laboratories, Inc.; Vice President, Research, Development and Quality at Somerset Pharmaceuticals, Inc.; Vice President, Research and Development at UDL Laboratories, Inc.; Director, Research and Development at AL Pharma and Senior Chemist at Carter-Wallace, Inc.

Dr. Bell is an affiliate professor of pharmacy at the College of Pharmacy at the Medical College of Virginia, Virginia Commonwealth University and an adjunct professor of Pharmaceutics, a member of the National Advisory Board and recipient of the Distinguished Alumnus Award from the College of Pharmacy, University of Florida. He also been published and has issued eight patents with several pending.

Dr. Bell is a member of the Council of Experts, General Chapters-Biological Analysis and the Joint Standards Subcommittee for United States Pharmacopeia, the American Society of Clinical Oncology, American Urology Association, International Society of Andrology, American College of Clinical Pharmacology and American Chemical Society. He is also an editorial advisory board member for the Journal of Chemical and Pharmaceutical Sciences and Enliven: Biosimilars and Bioavailability and co-editor for the book Poorly Soluble Drugs: Dissolution and Drug Release. He is also the past chair of the Analysis and Pharmaceutical Quality section for the American Association of Pharmaceutical Scientists, where he served in various leadership capacities.